domperidone has been researched along with opc 4392 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Momiyama, T; Sasa, M; Takaori, S | 1 |
| Ohno, Y; Sasa, M; Takaori, S | 1 |
2 other study(ies) available for domperidone and opc 4392
| Article | Year |
|---|---|
D-2 receptor-mediated inhibition by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), of dopaminergic neurons in the ventral tegmental area.
Topics: Animals; Benzazepines; Domperidone; Dopamine; Dopamine Agents; Electric Stimulation; Male; Neurons; Nucleus Accumbens; Piperazines; Quinolones; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Tegmentum Mesencephali | 1990 |
Presynaptic inhibition of excitatory input from the substantia nigra to caudate nucleus neurons by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392).
Topics: Action Potentials; Animals; Bromocriptine; Cats; Caudate Nucleus; Domperidone; Dopamine; Electric Stimulation; Neural Pathways; Neurons; Piperazines; Quinolines; Quinolones; Sodium Glutamate; Substantia Nigra | 1988 |